{
  "created_at": "Fri Nov 05 12:46:26 +0000 2021",
  "id_str": "1456346534090612743",
  "full_text": "Molnupiravir has been approved by Britain’s national medicines regulatory agency—the first in the world to do so\nhttps://t.co/ke8BBaVtrB",
  "display_text_range": [
    0,
    136
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/ke8BBaVtrB",
        "expanded_url": "https://econ.st/3k9sB5M",
        "display_url": "econ.st/3k9sB5M",
        "indices": [
          113,
          136
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 33,
  "favorite_count": 85,
  "possibly_sensitive": false,
  "original_created_at": "Thu Nov 04 19:44:05 +0000 2021"
}